Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

49 results about "Dienedione" patented technology

Dienedione, also known as estra-4,9-diene-3,17-dione, is a synthetic, orally active anabolic-androgenic steroid (AAS) of the 19-nortestosterone group that was never introduced for medical use. It is thought to be a prohormone of dienolone. The drug became a controlled substance in the US on January 4, 2010, and is classified as a Schedule III anabolic steroid under the United States Controlled Substances Act. Previous to this, it was sold as a bodybuilding supplement within the United States, and often mistakenly marketed as a prohormone for trenbolone, a veterinary steroid. Prior to its scheduling, it was part of a number of supplements that were seized during FDA enforcement of Bodybuilding.com for selling unapproved new drugs. The actual active metabolite, dienolone, is almost identical to trenbolone structurally, but lacks the C11 double bond.

Industrial process for the synthesis of 17a-acetoxy-11ss-[4-(n,n-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process

The present invention relates to a new industrial process for the synthesis of solvate- free 17a-acetoxy-11ss-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione [CDB -2914] of formula (I) which is a strong antiprogestogene and antiglucocorticoid agent. The invention also relates to compounds of formula (VII) and (VIII) used as intermediates in the process. The process according to the invention is the following: i) 3-(ethylene-dioxy)-estra-5(10),9(11)-diene-17-one of formula (X) is reacted with potassium acetilyde formed in situ in dry tetrahydrofuran by known method, ii) the obtained 3-(ethylene-dioxy)-17a-ethynyl-17ss-hydroxy-estra-5(10),9(11)-diene of formula (IX) is reacted with phenylsulfenyl chloride in dichloromethane in the presence of triethylamine and acetic acid, iii) the obtained isomeric mixture of 3-(ethylene-dioxy)-21-(phenyl-sulfinyl)-19-norpregna-5(10),9(11),17(20),20-tetraene of formula (VIII) is reacted first with sodium methoxide in methanol, then with trimethyl phosphite, iv) the obtained 3-(ethylene-dioxy)-17a-hydroxy-20-methoxy-19-norpregna-5(10),9(11),20-triene of formula (VII) is reacted with hydrogen chloride in methanol, then v) the obtained 3-(ethylene-dioxy)-17a-hydroxy-19-norpregna-5(10),9(11l); -diene-20- one of formula (VI) is reacted with ethylene glycol hi dichloromethane in the presence of trimethyl orthoformate and p-toluenesulfonic acid by known method, vi) the obtained 3,3,20,20-bis(ethylene-dioxy)-17a-hydroxy-19-norpregna- 5(10),9(11)-diene of formula (V) is reacted with hydrogen peroxide in a mixture of pyridine and dichloromethane in the presence of hexachloroacetone by known method, vii) the obtained 3,3,20,20-bis(ethylene-dioxy)-17a-hydroxy-5,10-epoxy-19-norpregn-9(11)-ene of formula (IV), containing approximately a 1:1 mixture of 5a,10a- and 5ss,10ss-epoxides, is isolated from the solution and reacted with a Grignard reagent obtained from 4-bromo-N,N-dimethyl-aniline in tetrahydrofuran.
Owner:RICHTER GEDEON NYRT

Phenylglycyl amino acid benzyl ester modified curcumin, synthesis, activity and application thereof

The invention discloses 1-(4)-Hydroxy-3-Methoxyphenyl)-7- Oxyacetylcarbamoyl-AA-OBzl-Methoxyphenyl)-1,6-Heptadiene-3,5-diketone of the following formula: (wherein AA is selected from L-Lys residue, L-Asn residue, L-Pro residue, L-Gln residue, L-Ser residue and L-Thr residue), the preparation methods are disclosed, and the antitumor growth activities are disclosed, the anti-inflammatory activitiesare disclosed, thus the use in the preparation of anti-tumor drugs and anti-inflammatory drugs is disclosed. The formulas are shown in the description.
Owner:CAPITAL UNIVERSITY OF MEDICAL SCIENCES

Preparation method of high-purity hydrocortisone

The invention discloses a preparation method of high-purity hydrocortisone, and belongs to the technical field of preparation and processing of medicines. According to the method, 17alpha-hydroxypregna-4, 9 (11)-diene-3, 20-diketone-21-acetate is used as a starting material, and the high-purity hydrocortisone is prepared through three steps of bromo-hydroxyl, debromination and hydrolysis. According to the preparation method of the high-purity hydrocortisone disclosed by the invention, the reaction process can be effectively shortened by improving the defects of a traditional process, the generation of impurities during the reaction process is controlled, the use of iodine with characteristics of high toxicity and environmental unfriendliness is avoided, the environmental pollution is reduced, and the method has characteristics of high overall conversion rate, simple operation and wide market prospect, and is suitable for industrial production.
Owner:ZHEJIANG SHENZHOU PHARMA

3-sterone-1, 2-dehydrogenase as well as gene sequence and application thereof

The invention provides 3-sterone-1, 2-dehydrogenase as well as a gene sequence and application thereof. The invention discloses a gene sequence for expressing 3-sterone-1, 2-dehydrogenase, the gene sequence is shown as SEQ ID. 4, and the gene sequence is used for expression in escherichia coli. The 3-ketosterone-1, 2-dehydrogenase disclosed by the invention can be used for efficiently catalyzing androstane-4-ene-3, 17-dione (4-AD) reaction to generate androstane-1, 4-diene-3, 17-dione (ADD), and has high enzymatic activity. In addition, the soluble 3-sterone-1, 2-dehydrogenase is obtained, andthe solubility of the enzyme is improved.
Owner:武汉艾默佳华生物科技有限公司

Preparation method for [17alpha, 16alpha-d] methyl oxazoline

The invention discloses a preparation method for a denazacort key intermediate [17alpha, 16alpha-d] methyl oxazoline steroids. The steps include: dissolving [16, 17alpha-epoxy-pregnane-20-methyl formate hydrazine acetyl-1,4-diene-3,11-diketone] in trichloromethane, adding [16, 17alpha-epoxy-pregnane-20-methyl formate hydrazine acetyl-1,4-diene-3,11-diketone] and additives into a pressure reaction kettle, leading ammonia to the reaction kettle to a certain pressure under the condition of stirring, and reacting at certain temperature; and dissolving the obtained compound crude products in glacial acetic acid, adding a certain amount of anhydride under the condition of stirring, and controlling reaction temperature. After the reaction, reaction liquid is poured into 500mL of cold 10% sodium hydroxide solution and stirred for 1 hours, and the denazacort key intermediate [17alpha, 16alpha-d] methyl oxazoline steroids is obtained after suction filtration. The method achieves safe and clean production of denazacort, is favorable for reducing environment pollution, shortens a production period, reduces production cost for enterprises, improves production safety, and is remarkable in social benefit, environment benefit and economical benefit.
Owner:JIANGXI JUNYE BIOLOGICAL PHARM CO LTD

Biological dehydrogenation method of androstenedione C1 and 2 loci

The invention relates to production methods of steroid medicine intermediates, and specifically relates to a biological dehydrogenation method of androstenedione C1 and 2 loci. The biological dehydrogenation method of the androstenedione C1 and 2 loci comprises the following steps: taking 4-androstene-3,17-dione as a substrate and simple nocardia bacterium fluid as an enzyme source, adding soybeanoil at a concentration of 100-200 ml/L and tween-80 at a concentration of 0.1-2 g/L into a transformation system, and carrying out transformation reaction at 29-31 DEG C until completion of the reaction so as to obtain a reaction product; and then, separating and purifying the reaction product so as to obtain the 1,4-androdiene-3,17-dione. On the basis of adopting a common direct conversion method, the soybean oil and the tween-80 are added according to the biological dehydrogenation method of the androstenedione C1 and 2 loci, so that conversion rate can be greatly improved that the conversion rate can be up to 96% or above; and moreover, the product is low in degradation rate, high in reaction specificity, relatively fast in conversion time and high in product quality. In addition, sterile environment is not required that only routine outdoor operation is enough; and thus, the biological dehydrogenation method of the androstenedione C1 and 2 loci is easy to operate, and suitable forindustrial large-scale production.
Owner:HUNAN NORCHEM PHARMACEUTICAL CO LTD

A method for treating 16α-methylandrost-4,9(11)-diene-3,17-dione mother liquor

The embodiment of the present invention provides a method for processing 16α-methylandrosta-4,9(11)-diene-3,17-dione mother liquor, the method comprising: adding a sufficient amount of carbonic acid to the mother liquor The salt is subjected to a precipitation reaction, and the precipitate is taken out after the reaction is complete to obtain crude lithium carbonate; the solution after the precipitation is taken out is distilled to a thick state, and then the thick liquid is filtered to obtain a filter residue and a filtrate; the filter residue is put into a strong alkali solution After mixing, leave it still to obtain a layered solution; take the upper layer of the layered solution to distill to obtain diisopropylamine; take the lower layer of the layered solution to pass through chlorine gas and add an organic solvent for extraction reaction to obtain bromine; The aqueous solution obtained after the extraction reaction is distilled together with the filtrate to obtain solid waste containing organic phosphorus. The embodiment of the present invention can effectively recover diisopropylamine, lithium, bromine and water in the 16α-methylandroster-4,9(11)-diene-3,17-dione mother liquor, and can efficiently remove the mother liquor organophosphorus in.
Owner:SHANDONG SITO BIO TECHNOLOGY CO LTD +1

Preparation method of dehydroxymethasone intermediate

The invention provides a preparation method of a dehydroxymethasone intermediate, which comprises the following steps: by taking 21-hydroxypregna-1, 4, 9 (11), 16-tetraene-3, 20-diketone-21-acetate as a starting material, sequentially carrying out bromine hydroxylation, epoxidation, methylation and hydrolysis reaction, so as to obtain the dehydroxymethasone intermediate 9beta, 11 beta-epoxy-21-hydroxy-16 alpha-methyl progesterone-1, 4-diene-3, 20-diketone. The preparation process route provided by the invention has fewer reaction steps, the quality and yield of the product have obvious competitiveness, dangerous chemical processes are not involved, the method is green and clean, and the atom economy is improved; the preparation process has a wide industrial application prospect.
Owner:JIANGSU YUANDA XIANLE PHARMA +1

Method for producing androstane dienedione through fermentation of arthrobacter simplex

The invention belongs to the technical field of preparation of steroid hormone drugs, and particularly relates to a method for producing androstane dienedione by fermentation of arthrobacter simplex, which mainly comprises the following steps: optimizing fermentation culture medium components, feeding points and substrates for whole-cell transformation of arthrobacter simplex to obtain an ADD crude product with high conversion rate, and extracting and refining by mixing acetone and water to obtain the androstane dienedione. And an ADD fine product is obtained. The method effectively solves the problems that in the prior art, the conversion efficiency is not high, byproducts are difficult to separate, the process is tedious and not suitable for industrial mass production, and the like, the fermentation feeding concentration is increased to 30-60 g / L, and the conversion rate is increased to 97% or above.
Owner:ZHEJIANG XIANJU PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products